中国生物科技企业法邦亮相西雅图分子病理年会 展示超级智能酶技术
分子病理协会2026年会11月10日至14日在西雅图会议中心举行，中国生物科技企业法邦参展，在1905号展位展示超级智能（SI）设计的酶、逆转录产品组合以及RNA与DNA文库制备全流程方案。
法邦11月11日上午10时至10时50分还将在会议中心三层塔霍马5号厅举办研讨会，由吴宁博士主讲，介绍从酶工程到实际应用的技术路径。分子病理年会是全球分子诊断与病理学领域的重要学术会议，今年吸引了来自各国的检验机构、医院实验室与生物技术企业参会。
法邦方面表示，公司希望借助年会平台与美国西部的临床实验室与科研机构建立合作，推动其酶与文库制备产品在北美市场的应用。西雅图作为美国西北部生物科技重镇，拥有华盛顿大学、弗雷德·哈钦森癌症中心等科研机构，近年来已成为中资生物科技企业开拓北美市场的重要落点。
Chinese Biotech Firm Fapon Showcases SI-Engineered Enzymes at Molecular Pathology Meeting in Seattle
The Association for Molecular Pathology’s 2026 annual meeting runs November 10-14 at the Seattle Convention Center, where Chinese biotechnology company Fapon is exhibiting at booth 1905, presenting its SI-engineered enzymes, reverse transcription product portfolio and end-to-end RNA and DNA library preparation workflows.
On November 11, from 10:00 to 10:50 a.m., Fapon will also hold a workshop in Tahoma Room 5 on the convention center’s third floor, where Dr. Ning Wu will present the technical path from enzyme engineering to practical applications. The molecular pathology meeting is a major global academic event in molecular diagnostics and pathology, drawing testing institutions, hospital laboratories and biotechnology companies from many countries this year.
Fapon said it hopes to use the meeting to build partnerships with clinical laboratories and research institutions in the western United States and to expand the use of its enzyme and library preparation products in the North American market. Seattle, a biotechnology hub in the Pacific Northwest and home to institutions such as the University of Washington and the Fred Hutchinson Cancer Center, has in recent years become an important foothold for Chinese biotech companies entering the North American market.
来源：美通社
发布：GSM·美国（发布链接）
图片来源：西雅图会议中心资料图。（A4LE）
GSM Global · 本篇英文版 English edition of this story
